← Back to Search

N/A

Dietary Changes for Psoriatic Arthritis (DIPSA Trial)

N/A
Recruiting
Led By Alexis Ogdie-Beatty, MD, MSCE
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Required Rheumatologist-confirmed diagnosis of PsA fulfilling Classification of Psoriatic Arthritis Criteria (CASPAR)
Stable treatment for PsA for ≥3 months prior to enrollment (patients may be on any disease modifying anti-rheumatic drugs (DMARDs) or they can be free of systemic medications
Timeline
Screening 3 weeks
Treatment Varies
Follow Up varying times: (at baseline) 0, 4, 8, 12, 16, 20, 24 weeks
Awards & highlights

DIPSA Trial Summary

This trial will test whether a change in diet can help people with psoriatic arthritis.

Who is the study for?
This trial is for adults aged 18-80 with a BMI between 25 and 40, diagnosed with Psoriatic Arthritis by a rheumatologist. Participants must have been on stable PsA treatment for at least three months, own a smartphone or be willing to use one provided, and are open to changing their diet for the study duration. Exclusions include eating disorders, certain medical conditions like insulin-dependent diabetes or advanced cancer, food allergies related to the study diets, inability to consent or read/write in English.Check my eligibility
What is being tested?
The trial is testing two different diets' effects on psoriatic arthritis over a period of 24 weeks. Patients will be assigned one of these diets and will need to adhere strictly while attending regular follow-up visits. The goal is to see if dietary changes can improve symptoms associated with PsA.See study design
What are the potential side effects?
Since this trial involves dietary interventions rather than medication, side effects may include changes in weight or digestive discomfort as participants adjust to new eating habits. Specific side effects will depend on individual health conditions and the nature of diet changes.

DIPSA Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My Psoriatic Arthritis diagnosis is confirmed by a rheumatologist.
Select...
I have been on a stable PsA treatment for at least 3 months.
Select...
I am between 18 and 80 years old.
Select...
I can go to all my follow-up appointments.

DIPSA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~varying times: (at baseline) 0, 4, 8, 12, 16, 20, 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and varying times: (at baseline) 0, 4, 8, 12, 16, 20, 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in Disease Activity in Psoriatic Arthritis (DAPSA)
Change in Psoriasis Area and Severity Index (PASI)
Metabolic Profile- Blood Glucose Studies
+12 more

DIPSA Trial Design

3Treatment groups
Active Control
Group I: Diet 3Active Control1 Intervention
Diet 3 will focus on healthy dietary patterns and provide nutritional support with a dietitian.
Group II: Diet 1Active Control1 Intervention
Diet 1 will focus on the dietary pattern and monitor types of foods, supplementary nutrition, and provide nutritional support with a dietitian.
Group III: Diet 2Active Control1 Intervention
Diet 2 will focus on the dietary pattern and monitor the amount of food, complimentary nutrition, and nutritional support with a dietitian.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,993 Previous Clinical Trials
42,875,473 Total Patients Enrolled
9 Trials studying Psoriatic Arthritis
3,339 Patients Enrolled for Psoriatic Arthritis
NYU Langone HealthOTHER
1,363 Previous Clinical Trials
816,396 Total Patients Enrolled
4 Trials studying Psoriatic Arthritis
1,220 Patients Enrolled for Psoriatic Arthritis
Women's College HospitalOTHER
99 Previous Clinical Trials
38,681 Total Patients Enrolled
2 Trials studying Psoriatic Arthritis
940 Patients Enrolled for Psoriatic Arthritis

Media Library

Diet 1 (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT04180904 — N/A
Psoriatic Arthritis Research Study Groups: Diet 3, Diet 1, Diet 2
Psoriatic Arthritis Clinical Trial 2023: Diet 1 Highlights & Side Effects. Trial Name: NCT04180904 — N/A
Diet 1 (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04180904 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Could I qualify to take part in this research project?

"This particular medical trial is only open to patients that suffer from psoriatic arthritis and are between 18-80 years old. The study has room for approximately 90 participants."

Answered by AI

Are people over the age of 35 able to join this trial?

"This study is recruiting patients aged 18 to 80. In contrast, 55 other clinical trials are only testing treatments on children and 334 are focused on elderly care."

Answered by AI

Are participants being recruited for this clinical trial at this time?

"The clinical trial is presently looking for volunteers, as seen on clinicaltrials.gov. This study was originally posted on 3/11/2021, with the most recent update being 1/6/2022."

Answered by AI

How many people are allowed to enroll in this experiment?

"The clinical trial is currently recruiting participants, as indicated by the most recent data from clinicaltrials.gov. The posting dates for this trial are 3/11/2021 and 1/6/2022 respectively. This study requires 90 individuals at 2 different sites."

Answered by AI
~15 spots leftby Nov 2024